Manufacturers/BE Pharmaceuticals Inc.

BE Pharmaceuticals Inc.

13 drugs in NADAC|13 Generic,0 Brand

BE Pharmaceuticals Inc. lists 13 NDCs in the CMS NADAC file (13 generic, 0 brand), at an average NADAC of $10.79 per unit, with a week-over-week move of -0.9% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

13

13G / 0B

Avg Price / Unit

$10.7936

$0.39 – $38.51

Avg 7d Change

-0.93%

Across 8 drugs with changes

7d Activity

355 flat

of 13 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does BE Pharmaceuticals Inc. make?

BE Pharmaceuticals Inc. lists 13 NDCs in the CMS NADAC file — 13 generic and 0 brand products.

What is the average price of BE Pharmaceuticals Inc. drugs?

The average NADAC across BE Pharmaceuticals Inc.'s portfolio is $10.7936 per unit, ranging from $0.3942 to $38.5080.

What types of drugs does BE Pharmaceuticals Inc. make?

BE Pharmaceuticals Inc. makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Low Molecular Weight Heparin (7), Lipopeptide Antibacterial (2), Substance P/Neurokinin-1 Receptor Antagonist (1), Proton Pump Inhibitor (1), Anticholinergic (1).

Has BE Pharmaceuticals Inc. had any drug recalls?

No FDA enforcement recalls are matched to BE Pharmaceuticals Inc. in the openFDA feed.

How has BE Pharmaceuticals Inc.'s pricing changed recently?

Over the past 7 days, 3 BE Pharmaceuticals Inc. products rose and 5 fell, with a portfolio-wide average change of -0.9%.

Drug Portfolio

13 drugs total, 13 shown